cp-55,940 has been researched along with gw 842166x in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Futaki, N; Iida, I; Ishizaka, T; Ohta, H; Saito, S; Tatsuzuki, M; Toda, Y; Tomishima, Y; Yamaguchi, T; Yoshinaga, M | 1 |
Chen, JZ; Chen, LL; Han, S; Pu, JB; Qian, HY; Xie, X; Zhang, FF | 2 |
Chen, JZ; Li, GJ; Pan, YL; Qian, HY; Wang, ZL; Xie, X; Xie, XY | 1 |
4 other study(ies) available for cp-55,940 and gw 842166x
Article | Year |
---|---|
Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action.
Topics: Animals; Humans; Imines; Male; Molecular Structure; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2008 |
Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor.
Topics: Animals; Calcium; CHO Cells; Coumarins; Cricetulus; Drug Design; Ligands; Molecular Docking Simulation; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Transfection | 2015 |
Development of Quinoline-2,4(1H,3H)-diones as Potent and Selective Ligands of the Cannabinoid Type 2 Receptor.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Ligands; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Multiple Sclerosis; Quantitative Structure-Activity Relationship; Quinolines; Receptor, Cannabinoid, CB2 | 2015 |
Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies.
Topics: Animals; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Pyridazines; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2017 |